Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland
Drug and Alcohol Review · 2024
DOI: 10.1111/dar.13893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, 2024. Verfasst von Pieter Baker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA. Hauptthemen laut MEDLINE: Harm Reduction, Substance Abuse, Intravenous. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIAID NIH HHS, Center for AIDS Research, Johns Hopkins University.
Abstract (Originalsprache)
Introduction
Given structural barriers, access to services is key for preventing drug‐related harms and managing chronic disease among people who inject drugs (PWID). The Patient Activation Measure (PAM), a validated scale to assess self‐efficacy in navigating one's own health care, was operationalised to improve service utilisation and outcomes but has not been assessed among PWID. We characterised PAM and its association with healthcare and harm reduction utilisation among PWID in the AIDS Linked to IntraVenous Experience cohort in Baltimore.
Methods
From 2019 to 2020, participants completed surveys on PAM, service utilisation and drug use. We used log‐binomial regression to identify correlates of “Lower” PAM and modelled the association between lower PAM and service utilisation, stratified by recent IDU.
Results
Participants ( n = 351) were primarily male (67%), Black (85%) and 24% reported recent IDU. Lower PAM was significantly more common in those reporting IDU (aPR 1.45; 95% CI 1.03, 2.04), heavy alcohol (aPR 1.77; 95% CI 1.24, 2.51) and marijuana (aPR: 1.70; 95% CI 1.23, 2.36) but less common among women (aPR 0.57; 95% CI 0.38, 0.84) and those living with HIV (APR 0.52; 95% CI 0.35, 0.78). In modelling service utilisation, lower PAM was associated with a lower prevalence of methadone utilisation (aPR 0.27; 95% CI 0.09, 0.84) among those reporting IDU, but a higher prevalence of methadone utilisation (aPR 2.72; 95% CI 1.46, 5.08) among those not reporting IDU, after controlling for correlates of PAM. Discussion and Conclusion PAM‐tailored interventions targeting methadone utilisation warrant consideration but should account for socio‐structural barriers to utilisation and correlates of PAM among PWID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA.
- Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, USA.
- School of Medicine, Johns Hopkins University, Baltimore, USA.
ORCID-Profile: Pieter Baker
Förderung
- NIDA NIH HHS
- NIAID NIH HHS
- Center for AIDS Research, Johns Hopkins University
- National Institute on Drug Abuse
Zitieren
APA
Baker, P., Genberg, B. L., Astemborski, J., Mehta, S. H., Kirk, G. D., & Cepeda, J. (2024). Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Review. https://doi.org/10.1111/dar.13893
Vancouver
Baker P, Genberg BL, Astemborski J, Mehta SH, Kirk GD, Cepeda J. Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland. Drug and Alcohol Review. 2024. doi:10.1111/dar.13893
BibTeX
@article{Baker2024,
author = {Baker, Pieter and Genberg, Becky L and Astemborski, Jacquie and Mehta, Shruti H and Kirk, Gregory D and Cepeda, Javier},
title = {Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland},
journal = {Drug and Alcohol Review},
year = {2024},
doi = {10.1111/dar.13893}
}
EUVIMED